Inventor
Katja Jantos
Inventor
Ludwigshafen, DE
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds49%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
A61KPreparations for medical, dental or toiletry purposes4%
C07BGeneral methods of organic chemistry2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
9,938,269Inhibitor compounds of phosphodiesterase type 10A20189,862,704'Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases'20189,840,495'Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases'20179,790,203'Inhibitor compounds of phosphodiesterase type 10A'20179,688,678'Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases'20179,657,002'Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases'20179,657,034'Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors'20179,617,226'Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases'20179,567,325'Carboxamide compounds and their use as calpain inhibitors'20179,527,856'Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases'20169,527,811'Carboxamide compounds and their use as calpain inhibitors'20169,273,036'Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases'20169,200,005'Inhibitor compounds of phosphodiesterase type 10A'20159,150,545'Carboxamide compounds and their use as calpain inhibitors V'20159,062,027'Carboxamide compounds and their use as calpain inhibitors V'20159,051,304'Carboxamide compounds and their use as calpain inhibitors V'20159,018,206'Carboxamide compounds and their use as calpain inhibitors'20158,906,941'Carboxamide compounds and their use as calpain inhibitors'20148,664,214'Small molecule potentiators of metabotropic glutamate receptors I'20148,598,211'Carboxamide compounds and their use as calpain inhibitors IV'20138,314,120'Small molecule potentiators of metabotropic glutamate receptors'20128,283,363'Carboxamide compounds and their use as calpain inhibitors'20128,236,798'Carboxamide compounds and their use as calpain inhibitors'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2018Patents assigned to JANTOS KATJA (10)· patent assignee history
2012–2015Patents assigned to HORNBERGER WILFRIED (7)· patent assignee history
2012–2015Patents assigned to KLING ANDREAS (7)· patent assignee history
2012–2018Based in Ludwigshafen, DE· patent location history
2013–2018Patents assigned to ABBVIE DEUTSCHLAND (20)· patent assignee history
2013–2018Patents assigned to ABBVIE INC (14)· patent assignee history
2014–2017Based in Mannheim, DE· patent location history
2015–2017Based in Wiesbaden, DE· patent location history
2015Based in Lugwigshafen, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE DEUTSCHLAND | 20 | 2013–2018 |
| ABBVIE INC | 14 | 2013–2018 |
| JANTOS KATJAself | 10 | 2012–2018 |
| HORNBERGER WILFRIED | 7 | 2012–2015 |
| KLING ANDREAS | 7 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ludwigshafen, DE | 14 | 2012–2018 |
| Wiesbaden, DE | 6 | 2015–2017 |
| Mannheim, DE | 2 | 2014–2017 |
| Lugwigshafen, DE | 1 | 2015 |